Smarter chemotherapy approach could delay drug resistance in ovarian cancer
30th April 2025
Adaptive chemotherapy can prolong survival in lab models of ovarian cancer, according to new results. The findings could pave the way for a more effective and gentler approach to treating ovarian cancer that uses existing drugs in a more intelligent way.
Read more
Introducing: Dr Alastair Lamb
3rd April 2025
Welcome to our newest group leader, Dr Alastair Lamb.
Read more
Barts Cancer Institute receives LEAF Awards for sustainability
19th March 2025
The Barts Cancer Institute (BCI), Queen Mary University of London, has been awarded the LEAF Bronze award for sustainability, achieving Bronze or Silver certification standards across each of our 15 laboratory sections.
Read more
Scientists identify strategy to make chemotherapy more effective for women with ovarian cancer
7th March 2025
Scientists have discovered a potential way to improve chemotherapy’s effect on ovarian cancer by manipulating specific immune cells around the tumour, potentially offering a way to help thousands of women with ovarian cancer benefit more from standard therapies and potentially delay relapses.
Read more
From MSc Cancer student to Principal Investigator – how do you build a research career?
26th February 2025
When Dr Alex Papachristodoulou joined our MSc programme at Barts Cancer Institute, Queen Mary University of London, he discovered his passion for cancer research and set out on a career path that led him to launch his own independent lab.
Read more
Scientists discover the ‘roadmap’ that aggressive cancer uses to spread around the body and identify ways to block its escape
14th February 2025
Scientists have discovered a new way to predict which tumours will become aggressive before they metastasise and spread around the body. The findings could help doctors spot which tumours are likely to be aggressive and cause metastatic cancer. They also open new avenues for treating cancer before it spreads.
Read more